-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $86

Benzinga·07/09/2026 17:46:02
Listen to the news
Needham analyst Joseph Stringer maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $105 to $86.